Post-ERCP Pancreatitis: Prevention, Diagnosis and Management

Autor:	Cahyadi O, Tehami N, De-Madaria E, Siau K
Jazyk:	litevština
Rok vydání:	2022
Předmět:	ERCP pancreatic stenting post-ERCP pancreatitis non-steroidal anti-inflammatory drugs
Zdroj:	MEDICINA-LITHUANIA r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante instname
ISSN:	1648-9144
Popis:	Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis (PEP) rate of 2-10%, which could be as high as 30-50% in high-risk cases. PEP is severe in up to 5% of cases, with potential for life-threatening complications, including multi-organ failure, peripancreatic fluid collections, and death in up to 1% of cases. The risk of PEP is potentially predictable and may be modified with pharmacological measures and endoscopist technique. This review covers the definition, epidemiology and risk factors for PEP, with a focus on the latest evidence-based medical and endoscopic strategies to prevent and manage PEP.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::70699692148b8c5aa06892be1989c78f https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9224 Zobrazit plný text záznamu